KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Income from Continuing Operations: 2014-2024

Historic Income from Continuing Operations for BeOne Medicines (ONC) over the last 11 years, with Dec 2024 value amounting to -$644.8 million.

  • BeOne Medicines' Income from Continuing Operations rose 202.88% to $124.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.5 million, marking a year-over-year increase of 107.97%. This contributed to the annual value of -$644.8 million for FY2024, which is 26.87% up from last year.
  • Per BeOne Medicines' latest filing, its Income from Continuing Operations stood at -$644.8 million for FY2024, which was up 26.87% from -$881.7 million recorded in FY2023.
  • Over the past 5 years, BeOne Medicines' Income from Continuing Operations peaked at -$644.8 million during FY2024, and registered a low of -$2.0 billion during FY2022.
  • For the 3-year period, BeOne Medicines' Income from Continuing Operations averaged around -$1.2 billion, with its median value being -$881.7 million (2023).
  • Per our database at Business Quant, BeOne Medicines' Income from Continuing Operations tumbled by 71.33% in 2020 and then skyrocketed by 56.00% in 2023.
  • Over the past 5 years, BeOne Medicines' Income from Continuing Operations (Yearly) stood at -$1.6 billion in 2020, then rose by 10.49% to -$1.5 billion in 2021, then slumped by 37.45% to -$2.0 billion in 2022, then spiked by 56.00% to -$881.7 million in 2023, then climbed by 26.87% to -$644.8 million in 2024.